5H-cyclopenta[D]pyrimidines as AKT protein kinase inhibitors
US8329709B2 · kind B2 · utility
10Cited by
2References
33Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 9, 2009 |
| Grant date | Dec 11, 2012 |
| Priority date | — |
| Expiry date | Jan 9, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds of Formula I are useful for inhibiting AKT protein kinases. Methods using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed. Formula (I).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.